Jeff Poulton
Chief Financial Officer, Alnylam

Jeff Poulton is the Chief Financial Officer at Alnylam, and brings 25 years of experience, including leading finance, business development and commercial operations at companies using differentiated technologies to develop treatments for patients with rare diseases. Prior to joining Alnylam, Jeff served as CFO at Indigo Agriculture, where he supported the initial commercial scale-up of the business, including expansion outside the US. Mr. Poulton previously held various roles of increasing responsibility at Shire Plc, concluding his service as CFO and a member of its Executive Committee and Board of Directors. During his tenure at Shire, Mr. Poulton led the rare disease commercial operations in the US, Latin America, and Asia Pacific, as well as its global rare disease business unit. Previously, he led corporate finance and business development initiatives in both the energy and materials manufacturing sectors in financial leadership positions at Cinergy Corp and PPG industries. He also served in the US Navy as a Commissioned Officer. Mr. Poulton has an MBA in Finance from the Kelley School of Business at Indiana University and a bachelor’s degree in Economics from Duke University. He also serves as a member of the Board of Directors at EIP Pharmaceuticals.